The Food and Drug Administration plans to complete its long-awaited review of abortion drugs in mid-December, but the public won’t see the results until March, according to a Wednesday filing from the Justice Department.
The 5th Circuit Court ordered the FDA to provide an update on its abortion pill safety review by Oct. 7, after the Justice Department requested a pause in a case challenging mail-order abortion in Louisiana.
Read Full Article: https://www.lifenews.com/2026/10/09/fda-delay-means-mail-order-abortions-will-likely-continue-into-2028/
